Figure 1. Schematic representation of 10 cases treated with RDV and other treatments for COVID-19 during hospitalization. Patient data were censored when the data were blocked on April 15, 2020. The black arrows indicate the 'symptomatic period', i.e., from the day the patient reported respiratory symptoms. The results of the SARS-CoV-2 PCR analysis of a sputum sample and a nasopharyngeal/pharyngeal swab are shown in parentheses. (+) Positive result. (-) Negative result. (Eq) Obvious result. (N) Patient was not examined.

RDV, remdesivir; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; PCR, polymerase chain reaction.